Effects of integrated traditional Chinese and Western medicine for acute pancreatitis: A real-world study in a tertiary teaching hospital

Abstract

Aim: This study aimed to evaluate whether integrated traditional Chinese medicine (TCM) and Western medicine (WM) is more effective than WM for acute pancreatitis (AP).

Methods: Patients with AP were enrolled and divided into the TCM and WM (TCM&WM) and WM groups according to the therapeutic protocol in real clinical settings. We applied 1:3 propensity score matching, which was to adjust confounding factors. The primary outcome was mortality, whereas the secondary outcomes were organ failure, organ supportive therapies, local complications, hospitalization cost, and length of hospital stay. Sensitivity and subgroup analyses were also performed.

Results: Of 5442 patients with AP, 4691 and 751 were included in the TCM&WM and WM groups, respectively. After PSM, patient baseline characteristics were well balanced. Compared with the WM group (n = 734), the TCM&WM group (n = 2096) had lower overall mortality rate (1.7% vs. 3.4%; risk ratio, 0.482; 95% confidence interval, 0.286–0.810; p = 0.005). The TCM&WM group was associated with lower risk of persistent renal failure, multiple organ failure, and infection, lower utilization of organ supportive therapies, shortened lengths of hospital and intensive care unit stay, and lower hospital costs. Sensitivity analyses showed similar results. Subgroup analysis favored TCM&WM treatment for patients aged < 60 years, with hypertriglyceridic etiology, and with admission interval between 24 and 48 h.

Conclusion: TCM&WM treatment can achieve lower risks of mortality and organ failure and better economic effectiveness in patients with AP than WM treatment. This study provides a promising alternative of TCM&WM treatment for AP in the real-world setting.

Keywords

acute pancreatitis / heat-disease theory / integrated traditional Chinese and Western medicine / real-world study / Western medicine

References

[1] ForsmarkCE,VegeSS, WilcoxCM. Acute pancreatitis. N Engl J Med. 2016;375(20):1972-1981.

[2] XiaoAY,TanML, WuLM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1(1):45-55.

[3] PetrovMS,YadavD. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):175-184.

[4] IannuzziJP,KingJA, LeongJH, et al. Global incidence of acute pancreatitis is increasing over time: a systematic review and meta-analysis. Gastroenterology. 2022;162(1):122-134.

[5] SchepersNJ,BakkerOJ, BesselinkMG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis. Gut. 2019;68(6):1044-1051.

[6] PetrovMS,Shanbhag S,ChakrabortyM,PhillipsAR,WindsorJA. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010;139(3):813-820.

[7] BanksPA,BollenTL, DervenisC, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-111.

[8] ZhaoYQ,LiuXH, ItoT,QianJM. Protective effects of rhubarb on experimental severe acute pancreatitis. World J Gastroenterol. 2004;10(7):1005-1009.

[9] DuD,YaoL, ZhangR, et al. Protective effects of flavonoids from Coreopsis tinctoria Nutt. on experimental acute pancreatitis via Nrf-2/ARE-mediated antioxidant pathways. J Ethnopharmacol. 2018;224:261-272.

[10] WenY,HanC, LiuT, et al. Chaiqin chengqi decoction alleviates severity of acute pancreatitis via inhibition of TLR4 and NLRP3 inflammasome: identification of bioactive ingredients via pharmacological sub-network analysis and experimental validation. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2020;79:153328.

[11] ChenW,YangX, HuangL, et al. Qing-Yi decoction in participants with severe acute pancreatitis: a randomized controlled trial. Chin Med. 2015;10:11.

[12] HuangP,LiYH, JiangJM. Summary of the concept of heart disease and the theory of Yihuo Qingxia proposed by professor Jiang Junming. Sich Trad Chin Med. 2008;26(1):1-2.

[13] XiaQ,HuangZW, JiangJM, et al. “Yi-Huo-Qing-Xia” method as the main therapy in integrated traditional Chinese and Western medicine on severe acute pancreatitis: a report of 1 161 cases. Chin J TCM WM Crit Care. 2004;13(3):131-134.

[14] LiuXBJJ,HuangZW, TianBL, et al. Clinical study on the treatment of severe acute pancreatitis by integrated traditional Chinese medicine and Western medicine. Sichuan da xue xue bao Yi xue ban = J Sichuan Univ Med Sci Ed. 2004;35(2):204-208.

[15] LiLLS,ZhangX, HeW, et al. Predicting persistent acute respiratory failure in acute pancreatitis: the accuracy of two lung injury indices. Dig Dis Sci. 2023;68(7):2878-2889.

[16] von ElmE,AltmanDG, EggerM,Pocock SJ,GøtzschePC,VandenbrouckeJP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.

[17] TennerS,BaillieJ, DeWittJ,Vege SS. American College of Gastroenterology Guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400-1415. 16.

[18] CrockettSD,WaniS, GardnerTB,Falck-Ytter Y,BarkunAN. American Gastroenterological Association Institute Guideline on initial management of acute pancreatitis. Gastroenterology. 2018;154(4):1096-1101.

[19] ChenZ,YangX, GuoJ, et al. AGI grade-guided chaiqin chengqi decoction treatment for predicted moderately severe and severe acute pancreatitis (CAP trial): study protocol of a randomised, double-blind, placebo-controlled, parallel-group, pragmatic clinical trial. Trials. 2022;23(1):933.

[20] AustinPC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399-424.

[21] RosenbaumPR,RubinDBJB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.

[22] KaplanNM,SproulLE, MulcahyWS. Large prospective study of ramipril in patients with hypertension. CARE Investigators. Clin Ther. 1993;15(5):810-818.

[23] AustinPC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150-161.

[24] LaiT,LiJ, ZhouZ, et al. Etiological changes and prognosis of hospitalized patients with acute pancreatitis over a 15-year period. Dig Dis Sci. 2024;69(1):56-65.

[25] WuD,LuB, XueHD, et al. Validation of modified determinant-based classification of severity for acute pancreatitis in a tertiary teaching hospital. Pancreatology. 2019;19(2):217-223.

[26] ZhuY,PanX, ZengH, et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the Revised Atlanta Classification in Jiangxi, China over an 8-year period. Pancreas. 2017;46(4):504-509.

[27] LuX,XiaoW, KangX,Yu J,FanZ. The effect of Chinese herbal medicine on non-biliogenic severe acute pancreatitis: a systematic review and meta-analysis. J Ethnopharmacol. 2014;155(1):21-29.

[28] LinJ,HanC, DaiN,BiS, DuD,XiaQ. Effectiveness of Chengqi-series decoctions in treating severe acute pancreatitis: a systematic review and meta-analysis. Phytomedicine: Int J Phytotherap Phytopharmacol. 2023;113:154727.

RIGHTS & PERMISSIONS

2024 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.